Invention Grant
US09241976B2 Use of HDL-related molecules to treat and prevent proinflammatory conditions
有权
使用HDL相关分子治疗和预防炎症性疾病
- Patent Title: Use of HDL-related molecules to treat and prevent proinflammatory conditions
- Patent Title (中): 使用HDL相关分子治疗和预防炎症性疾病
-
Application No.: US14239530Application Date: 2012-08-29
-
Publication No.: US09241976B2Publication Date: 2016-01-26
- Inventor: Robin Farias-Eisner , Srinivasa T. Reddy
- Applicant: Robin Farias-Eisner , Srinivasa T. Reddy
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: canady + lortz LLP
- Agent Karen S. Canady
- International Application: PCT/US2012/052925 WO 20120829
- International Announcement: WO2013/033260 WO 20130307
- Main IPC: C07K14/775
- IPC: C07K14/775 ; A61K38/17 ; A61K38/16

Abstract:
Molecules and compositions are described for use in the treatment and prevention of pro-inflammatory conditions. HDL-related molecules, including ApoA-I, bovine HDL and HDL mimetics, in particular, are demonstrated to prevent UV-induced cell death and oxidative stress in skin cells and to inhibit tumor growth and development in a variety of cancers. HDL-related molecules can be used as an oral supplement and in other compositions to prevent or treat pro-inflammatory skin conditions and systemic proinflammatory conditions, including Alzheimer's disease and various cancers.
Public/Granted literature
- US20140323410A1 USE OF HDL-RELATED MOLECULES TO TREAT AND PREVENT PROINFLAMMATORY CONDITIONS Public/Granted day:2014-10-30
Information query